These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 13804475)

  • 61. Re: Mastectomy and oophorectomy by menstrual cycle phase in women with operable breast cancer.
    Hrushesky WJ
    J Natl Cancer Inst; 2002 Nov; 94(22):1720-1. PubMed ID: 12441329
    [No Abstract]   [Full Text] [Related]  

  • 62. Immediate oophorectomy and adrenalectomy in metastic breast cancer.
    DRAGSTEDT LR
    Proc Natl Acad Sci U S A; 1961 Jul; 47(7):1069-71. PubMed ID: 13724246
    [No Abstract]   [Full Text] [Related]  

  • 63. Oophorectomy and radiation therapy for the breast cancer patient with early metastasis.
    Fratkin LB
    Am Surg; 1974 Sep; 40(9):509-10. PubMed ID: 4853471
    [No Abstract]   [Full Text] [Related]  

  • 64. Castration in the treatment of advanced breast cancer.
    Lewison EF
    Cancer; 1965 Dec; 18(12):1558-62. PubMed ID: 5845797
    [No Abstract]   [Full Text] [Related]  

  • 65. [Results of bilateral ovariectomy in the treatment of advanced cancer of the breast].
    Torres Trujillo R; Reyna R; Puño Cornejo E
    Ginecol Obstet Mex; 1979 May; 45(271):401-9. PubMed ID: 540775
    [No Abstract]   [Full Text] [Related]  

  • 66. [OOPHORECTOMY AND BREAST CANCER].
    KOERBLER J
    Krebsarzt; 1965; 20():30-40. PubMed ID: 14271391
    [No Abstract]   [Full Text] [Related]  

  • 67. Prophylactic mastectomy with immediate reconstruction combined with simultaneous laparoscopic salpingo-oophorectomy via a transmammary route: a novel surgical approach to female BRCA-mutation carriers.
    Perabò M; Fink V; Günthner-Biller M; von Bodungen V; Friese K; Dian D
    Arch Gynecol Obstet; 2014 Jun; 289(6):1325-30. PubMed ID: 24389920
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.
    Metcalfe KA; Lubinski J; Ghadirian P; Lynch H; Kim-Sing C; Friedman E; Foulkes WD; Domchek S; Ainsworth P; Isaacs C; Tung N; Gronwald J; Cummings S; Wagner T; Manoukian S; Møller P; Weitzel J; Sun P; Narod SA;
    J Clin Oncol; 2008 Mar; 26(7):1093-7. PubMed ID: 18195327
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A diagnostic dilemma following risk-reducing surgery for BRCA1 mutation - a case report of primary papillary serous carcinoma presenting as sigmoid cancer.
    Chand M; Moore PJ; Clarke AD; Nash GF; Hickisk T
    World J Surg Oncol; 2007 Sep; 5():102. PubMed ID: 17850658
    [TBL] [Abstract][Full Text] [Related]  

  • 70. STUDIES ON URINARY ESTROGENS IN PATIENTS WITH ADVANCED BREAST CANCER IN REFERENCE TO OOPHORECTOMY AND ADRENALECTOMY.
    UKAI M
    Nagoya J Med Sci; 1964 Sep; 27():36-62. PubMed ID: 14213655
    [No Abstract]   [Full Text] [Related]  

  • 71. An aggressive multimodality approach to locally advanced carcinoma of the breast.
    Osteen RT; Chaffey JT; Moore FD; Wilson RE
    Surg Gynecol Obstet; 1978 Jul; 147(1):75-9. PubMed ID: 96542
    [TBL] [Abstract][Full Text] [Related]  

  • 72. TOTAL HYSTERECTOMY COMBINED WITH PROPHYLACTIC BILATERAL OOPHORECTOMY IN TREATMENT OF BREAST CANCER.
    VARDEN LC; RICHTMEYER DC
    Va Med Mon (1918); 1963 Oct; 90():501-4. PubMed ID: 14069382
    [No Abstract]   [Full Text] [Related]  

  • 73. Primary peritoneal serous carcinoma presenting as inflammatory breast cancer.
    Khalifeh I; Deavers MT; Cristofanilli M; Coleman RL; Malpica A; Gilcrease MZ
    Breast J; 2009; 15(2):176-81. PubMed ID: 19292804
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Re: Mastectomy and oophorectomy by menstrual cycle phase in women with operable breast cancer.
    Ferretti G; Di Cosimo S; Carlini P; Papaldo P; Fabi A; Cognetti F
    J Natl Cancer Inst; 2002 Nov; 94(22):1720; author reply 1721-2. PubMed ID: 12441330
    [No Abstract]   [Full Text] [Related]  

  • 75. [The place of one-stage bilateral ovariectomy and adrenalectomy in the treatment of advanced cancer of the breast. (Problems of operative tractics and re-equilibration)].
    SERAFINO X; SERAFINO G
    Mars Chir; 1961; 13():191-202. PubMed ID: 13750158
    [No Abstract]   [Full Text] [Related]  

  • 76. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
    Rebbeck TR; Lynch HT; Neuhausen SL; Narod SA; Van't Veer L; Garber JE; Evans G; Isaacs C; Daly MB; Matloff E; Olopade OI; Weber BL;
    N Engl J Med; 2002 May; 346(21):1616-22. PubMed ID: 12023993
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Bilateral synchronous adrenal metastasis of invasive ductal carcinoma treated with multimodality therapy including adrenalectomy and oophorectomy.
    Eren OO; Ordu C; Selcuk NA; Akosman C; Ozturk MA; Özkan F; Gokce Ö; Oyan B
    J Oncol Pharm Pract; 2016 Feb; 22(1):157-60. PubMed ID: 25227232
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Combined treatment of breast cancer].
    Karachunskiĭ MS
    Klin Khir (1962); 1971 Aug; 8():73-4. PubMed ID: 4328596
    [No Abstract]   [Full Text] [Related]  

  • 79. [Endocrine therapy of metastatic breast cancer].
    FIRMAT J; ALVAREZ AS
    Rev Argent Endocrinol Metab; 1958 Mar; 4(1):68-104. PubMed ID: 13579366
    [No Abstract]   [Full Text] [Related]  

  • 80. Risk-reduction mastectomy: clinical issues and research needs.
    Stefanek M; Hartmann L; Nelson W
    J Natl Cancer Inst; 2001 Sep; 93(17):1297-306. PubMed ID: 11535704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.